Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (641-650 of 934) with videos related to

Pageof 94
Sort By:
Diabetes, Obesity & Metabolism|February 15, 2022
Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trialJennifer Y Barraclough, Jie Yu, Gemma A Figtree, et al.
The American Journal of Cardiology|November 6, 2013
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart diseaseAntonio M Gotto, Christopher P Cannon, Xiujiang Susie Li, et al.
JAMA Cardiology|June 16, 2021
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the USChristopher P Cannon, James A de Lemos, Robert S Rosenson, et al.
Annals of Internal Medicine|December 31, 1997
A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: recommendations and potential impactG Nichol, R Walls, L Goldman, et al.
Circulation. Cardiovascular Quality and Outcomes|January 20, 2011
Randomized trial of targeted performance feedback to facilitate quality improvement in acute myocardial infarction careKaren P Alexander, Tracy Y Wang, Shuang Li, et al.
Cardiovascular Therapeutics|September 3, 2011
Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugsHenry Krum, Gary Swergold, Arnold Gammaitoni, et al.
Journal of the American College of Cardiology|April 1, 1994
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trialC P Cannon, C H McCabe, T D Henry, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registriesMatthew T Roe, Anita Y Chen, Christopher P Cannon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2014
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trialGregory Ducrocq, Phillip J Schulte, Richard C Becker, et al.
JACC. Advances|December 4, 2025
GOULD EDU: Cluster-Randomized Trial of an Educational Intervention to Improve Lipid-Lowering Guideline AdherenceChristopher P Cannon, Christie M Ballantyne, Deepak L Bhatt, et al.
Pageof 94

Showing results (641-650 of 934) with videos related to

Sort By:
Pageof 94
Diabetes, Obesity & Metabolism|February 15, 2022
Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trialJennifer Y Barraclough, Jie Yu, Gemma A Figtree, et al.
The American Journal of Cardiology|November 6, 2013
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart diseaseAntonio M Gotto, Christopher P Cannon, Xiujiang Susie Li, et al.
JAMA Cardiology|June 16, 2021
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the USChristopher P Cannon, James A de Lemos, Robert S Rosenson, et al.
Annals of Internal Medicine|December 31, 1997
A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: recommendations and potential impactG Nichol, R Walls, L Goldman, et al.
Circulation. Cardiovascular Quality and Outcomes|January 20, 2011
Randomized trial of targeted performance feedback to facilitate quality improvement in acute myocardial infarction careKaren P Alexander, Tracy Y Wang, Shuang Li, et al.
Cardiovascular Therapeutics|September 3, 2011
Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugsHenry Krum, Gary Swergold, Arnold Gammaitoni, et al.
Journal of the American College of Cardiology|April 1, 1994
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trialC P Cannon, C H McCabe, T D Henry, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registriesMatthew T Roe, Anita Y Chen, Christopher P Cannon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2014
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trialGregory Ducrocq, Phillip J Schulte, Richard C Becker, et al.
JACC. Advances|December 4, 2025
GOULD EDU: Cluster-Randomized Trial of an Educational Intervention to Improve Lipid-Lowering Guideline AdherenceChristopher P Cannon, Christie M Ballantyne, Deepak L Bhatt, et al.
Pageof 94